Search Results
Results for: SALVARX GROUP, JAMES MELLON (Save this search)
Number of Results: 4
Portage Awaits CSE Review, Shareholder Vote for Acquisition of SalvaRx
11 October 2018 - Canadian biotechnology company Portage Biotech Inc (CSE: PBT.U) (OTC: PTGEF) continues to await final work toward obtaining shareholder approvals for its acq...

PORTAGE AWAITS CSE REVIEW, SHAREHOLDER VOTE FOR ACQUISITION OF SALVARX
Canadian biotechnology company Portage Biotech Inc (CSE: PBT.U) (OTC: PTGEF) continues to await final work toward obtaining shareholder approvals for its acquisition of 100% o...

Portage to Acquire Immuno-Oncology Specialist SalvaRx
15 August 2018 - Canadian biotechnology company Portage Biotech Inc (CSE: PBT.U) (OTC: PTGEF) Portage Biotech Inc. has reached a definitive agreement to acquire 100% of immuno...

PORTAGE TO ACQUIRE IMMUNO-ONCOLOGY SPECIALIST SALVARX
Canadian biotechnology company Portage Biotech Inc (CSE: PBT.U) (OTC: PTGEF) Portage Biotech Inc. has reached a definitive agreement to acquire 100% of immuno-oncology special...
















You can compare news articles by clicking on the tick buttons